Stone House Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9K Buy
430
+17
+4% +$1.31K 0.01% 230
2025
Q4
$32.8K Sell
413
-31
-7% -$2.44K 0.01% 205
2025
Q3
$33.5K Sell
444
-71
-14% -$4.87K 0.01% 187
2025
Q2
$35.5K Sell
515
-57
-10% -$3.74K 0.01% 178
2025
Q1
$38.8K Buy
+572
New +$34.2K 0.01% 162
2024
Q4
Sell
-436
Closed -$27.4K 125
2024
Q3
$27.4K Sell
436
-116
-21% -$6.77K 0.01% 157
2024
Q2
$32.6K Sell
552
-219
-28% -$13.7K 0.01% 154
2024
Q1
$61.5K Buy
+771
New +$58.9K 0.01% 110
2023
Q3
Sell
-26
Closed -$1.81K 345
2023
Q2
$1.81K Buy
+26
New +$1.85K ﹤0.01% 274

Other funds holding CVS

Stone House Investment Management's CVS Position: Q1 2026 in Review

Stone House Investment Management increased its CVS Health (CVS) stake by 4.1% in Q1 2026, buying an estimated $1.31K and bringing the position to 430 shares worth $30.9K. The position accounts for 0.01% of the portfolio, ranked #230.

Stone House Investment Management first reported a position in CVS in Q2 2023 and has held it in 9 quarters since. The position peaked at $61.5K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Stone House Investment Management held 430 shares of CVS Health worth $30.9K as of Q1 2026.
  • Stone House Investment Management bought 17 CVS Health shares in Q1 2026, an estimated $1.31K.
  • CVS Health made up 0.01% of Stone House Investment Management's portfolio in Q1 2026, its #230 holding.
  • Stone House Investment Management first reported a position in CVS Health in Q2 2023 and has held it in 9 quarters since.
  • Stone House Investment Management's CVS Health position peaked at $61.5K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.